» Articles » PMID: 26879375

Hydrogen Sulfide Promotes Angiogenesis by Downregulating MiR-640 Via the VEGFR2/mTOR Pathway

Overview
Specialties Cell Biology
Physiology
Date 2016 Feb 17
PMID 26879375
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

We previously found hydrogen sulfide (H2S) to be a new proangiogenic factor. However, the mechanisms underlying the cardiovascular effect of this small gas molecule remain largely unknown. The aim of the present study was to identify the essential microRNAs (miRNAs) involved in the transduction of H2S signals in vascular endothelial cells (ECs). The expression of miR-640 and its signaling elements, vascular endothelial growth factor receptor 2 (VEGFR2), hypoxia inducible factor 1-α (HIF1A), and mammalian target of rapamycin (mTOR), was measured using quantitative PCR and Western blotting. Overexpression and inhibition of miR-640 were performed to clarify their roles in mediating the effect of H2S. In addition, knockdown of VEGFR2, HIF1A, and mTOR was performed using siRNAs, dominant negative mutants, or inhibitors to examine their roles in the transduction of the H2S signals. miR-640 levels decreased in vascular ECs that were treated with H2S, whereas overexpression of miR-640 blunted the proangiogenic effect of H2S. Knockdown of either VEGFR2 or mTOR blunted the downregulation of miR-640 and the proangiogenic effect induced by H2S. In addition, miR-640 bound to the 3'-UTR of HIF1A mRNA and then inhibited the expression of HIF1A. The inhibition could be recovered by treating cells with H2S. Thus we concluded that miR-640 plays a pivotal role in mediating the proangiogenic effect of H2S; H2S acts through downregulation of the expression of miR-640 and increasing the levels of HIF1A through the VEGFR2-mTOR pathway.

Citing Articles

Hydrogen Sulfide can Scavenge Free Radicals to Improve Spinal Cord Injury by Inhibiting the p38MAPK/mTOR/NF-κB Signaling Pathway.

Lin K, Zhang Y, Shen Y, Xu Y, Huang M, Liu X Neuromolecular Med. 2024; 26(1):26.

PMID: 38907170 DOI: 10.1007/s12017-024-08794-1.


The interplay of hydrogen sulfide and microRNAs in cardiovascular diseases: insights and future perspectives.

Song Y, Cao S, Sun X, Chen G Mamm Genome. 2024; 35(3):309-323.

PMID: 38834923 DOI: 10.1007/s00335-024-10043-6.


Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review.

Youness R, Habashy D, Khater N, Elsayed K, Dawoud A, Hakim S Noncoding RNA. 2024; 10(1).

PMID: 38250807 PMC: 10801522. DOI: 10.3390/ncrna10010007.


Targeting Homocysteine and Hydrogen Sulfide Balance as Future Therapeutics in Cancer Treatment.

Majumder A Antioxidants (Basel). 2023; 12(8).

PMID: 37627515 PMC: 10451792. DOI: 10.3390/antiox12081520.


The Triple Crown: NO, CO, and HS in cancer cell biology.

Oza P, Kashfi K Pharmacol Ther. 2023; 249:108502.

PMID: 37517510 PMC: 10529678. DOI: 10.1016/j.pharmthera.2023.108502.